Αποτελέσματα Αναζήτησης
21 Απρ 2023 · The epidemiology, clinical features, diagnosis, and treatment of infections due to K. pneumoniae will be reviewed here. The microbiology and pathogenesis of K. pneumoniae infection are discussed separately.
- Keri K Hall, Md, Ms
Clinical features, diagnosis, and treatment of Klebsiella...
- Tsay Rw, SIU Lk, Fung Cp, Chang Fy. Characteristics of Bacteremia Between Community-Acquired and Nosocomial Klebsiella Pneumoniae Infection: Risk Factor for Mortality and The Impact of Capsular Serotypes as a Herald for Community-Acquired Infection. Arch Intern Med 2002; 162:1021
Klebsiella pneumoniae liver abscesses, which were all...
- Keri K Hall, Md, Ms
The optimal approach to the treatment of infections caused by these multidrug-resistant strains remains undefined, and treatment decisions for an individual patient should be based on a number of organism- (for example, minimum inhibitory concentration) and patient-specific (for example, site of infection) factors.
20 Ιουλ 2023 · Treatment / Management. Go to: Differential Diagnosis. All organisms that typically cause community-acquired and hospital-acquired pneumonia, such as Staphylococcus, Pneumococcus, Pseudomonas, Acinetobacter, and Legionella. Tuberculosis. Aspergillus infection. Malignancy.
18 Αυγ 2022 · Summary. We retrospectively analyzed published data on the use and outcomes of antimicrobial therapy for K. pneumoniae infections. We discussed plazomicin, eravacycline, fosfomycin, tigecycline, and polymyxin as prevalent therapeutic options.
The treatment guidelines provide the first ever consensus recommendations for colistin and polymyxin B therapy that are intended to guide optimal clinical use. 19 A recent global survey revealed that polymyxins are available in most countries worldwide, but majority use colistin and a few use polymyxin B. 21
16 Οκτ 2018 · Treatment of Klebsiella pneumonia has discrepant results. For patients with severe infections, a clinically prudent approach is the use of an initial short course (48-72 h) of combination...
Section: This document is an update of the original 1993 statement on community-acquired pneumonia, incorporating new information about bacteriology, patient stratification, diagnostic evaluation, antibiotic therapy, and prevention.
